Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00818701 · ClinicalTrials.gov registry record · Phase 1
Study of Low Dose Nesiritide With or Without Sildenafil in Congestive Heart Failure Patients With Renal Dysfunction
A Phase 1 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT00818701: Clinical Trial Phase 1 study, sponsored by Mayo Clinic.
NCT00818701 is a Phase 1 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00818701, a Phase 1 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of the study is to show that low dose recombinant BNP coupled with phosphodiesterase V inhibition will improve renal dysfunction and promote relief of volume overload in patinets with acute decompensated heart failure complicated by the cardiorenal syndrome.
Interventions
- DRUG low dose Nesiritide
- DRUG nesiritide, Sildenafil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2009-02 |
| Est. Completion | 2010-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00818701
The ClinicalTrials.gov registry entry for NCT00818701 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which low dose Nesiritide is the first listed.
NCT00818701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00818701 about?
NCT00818701 is a clinical study titled "Study of Low Dose Nesiritide With or Without Sildenafil in Congestive Heart Failure Patients With Renal Dysfunction". The purpose of the study is to show that low dose recombinant BNP coupled with phosphodiesterase V inhibition will improve renal dysfunction and promote relief of volume overload in patinets with acute decompensated heart failure complicated by the cardiorenal syndrome.
What is the current status of trial NCT00818701?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2009-02. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00818701?
The interventions under investigation include: low dose Nesiritide (DRUG), nesiritide, Sildenafil (DRUG).
Who is sponsoring clinical trial NCT00818701?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.